Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2025 ,inter alia, to consider and approve audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech Limited has informed BSE that its Board meeting to consider and approve the audited financial results (standalone and consolidated) for Q4 and the financial year ended 31st March 2025 has been rescheduled to 9th June 2025. The original deadline for submission was 30th May 2025 as per SEBI's Listing Regulations. The company has cited administrative delays, specifically the consolidation of results from subsidiaries and the completion of internal and external audit processes, as the reasons for the delay. The trading window for designated persons will remain closed until 48 hours after the declaration of results.
While the delay is attributed to procedural and audit-related reasons rather than business issues, late submission of audited results may raise minor governance and compliance concerns among investors. Shareholders should watch the 9th June announcement closely for actual financial performance details.